Association of nitric oxide synthase and matrix metalloprotease single nucleotide polymorphisms with preeclampsia and its complications

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Leonardo, Daniela P ^a   Albuquerque, Dulcinéia M ^a   Lanaro, Carolina ^a   Baptista, Letícia C ^a   Cecatti, José G ^a   Surita, Fernanda G ^a   Parpinelli, Mary A ^a   Costa, Fernando F ^a   Franco Penteado, Carla F ^a   Fertrin, Kleber Y ^a   Costa, Maria Laura ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GELATINASE B; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; BODY HEIGHT; BODY WEIGHT; BRAZIL; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECLAMPSIA; FEMALE; HELLP SYNDROME; HUMAN; INTRON; MAJOR CLINICAL STUDY; MMP2 GENE; MMP9 GENE; NOS3 GENE; PREECLAMPSIA; PROSPECTIVE STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT; CLINICAL TRIAL; GENETICS; PREGNANCY;

ADULT; BRAZIL; CASE-CONTROL STUDIES; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84943303073     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136693     Document Type: Article

References (50)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644. doi: 10.1016/S0140-6736 (10) 60279-6 PMID: 20598363
2. Von Dadelszen P, Magee LA. Pre-eclampsia: an update. Curr Hypertens Rep. 2014;16:454. doi: 10. 1007/s11906-014-0454-8 PMID: 24915961
3. Souza JP, Gülmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet. 2013;381:1747-1755. doi: 10.1016/S0140-6736 (13) 60686-8 PMID: 23683641
4. Zanette E, Parpinelli MA, Surita FG, Costa ML, Haddad SM, Sousa MH, et al. Maternal near miss and death among women with severe hypertensive disorders: a Brazilian multicenter surveillance study. Reprod Heal. 2014;11:4. doi: 10.1186/1742-4755-11-4
5. Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol. 2014;63:1815-1822. doi: 10.1016/j.jacc.2014.02.529 PMID: 24613324
6. Creanga AA, Berg CJ, Ko JY, Farr SL, Tong VT, Bruce FC, et al. Maternal mortality and morbidity in the United States: where are we now? J Womens Heal. 2014;23:3-9. doi: 10.1089/jwh.2013.4617
7. Gynecologists AC of O and, Pregnancy TF on H in. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obs Gynecol. 2013;122:1122-1131. doi: 10.1097/01. AOG.0000437382.03963.88
8. Hsu P, Nanan RK. Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol. 2014;5:125. doi: 10.3389/fimmu.2014.00125 PMID: 24734032
9. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A. 2004;130 A: 365-371. doi: 10.1002/ajmg.a.30257 PMID: 15384082
10. Fong FM, Sahemey MK, Hamedi G, Eyitayo R, Yates D, Kuan V, et al. Maternal genotype and severe preeclampsia: a HuGE review. Am J Epidemiol. 2014;180:335-345. doi: 10.1093/aje/kwu151 PMID: 25028703
11. Haram K, Mortensen JH, Nagy B. Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy. 2014;2014:910751. doi: 10.1155/2014/910751 PMID: 24991435
12. Abou El Hassan M, Diamandis EP, Karumanchi SA, Shennan AH, Taylor RN. Preeclampsia: An Old Disease with New Tools for Better Diagnosis and Risk Management. Clin Chem. 2015; doi: 10.1373/clinchem.2014.230565
13. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall A V, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268:17478-17488. Available: http://www.ncbi.nlm.nih.gov/pubmed/7688726 PMID: 7688726
14. Southan GJ, Szabó C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol. 1996;51:383-394. Available: http://www.ncbi.nlm.nih.gov/pubmed/8619882 PMID: 8619882
15. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med. 1996;2:41-45. Available: http://www.ncbi.nlm.nih.gov/pubmed/8564837 PMID: 8564837
16. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, et al. A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999;100:1515-1520. Available: http://www.ncbi.nlm.nih.gov/pubmed/10510054 PMID: 10510054
17. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Ogawa H, Kugiyama K, et al. T (-786)-> C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol. 2000;86:628-634. Available: http://www.ncbi.nlm.nih.gov/pubmed/10980213 PMID: 10980213
18. Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension. 2001;38:1289-1293. Available: http://www.ncbi.nlm.nih.gov/pubmed/11751705 PMID: 11751705
19. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol. 2006;164:921-935. doi: 10.1093/aje/kwj302 PMID: 17018701
20. Yoshimura T, Yoshimura M, Tabata A, Shimasaki Y, Nakayama M, Miyamoto Y, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig. 2000;7:238-241. Available: http://www.ncbi.nlm.nih.gov/pubmed/10964023 PMID: 10964023
21. Kobashi G, Yamada H, Ohta K, Kato E, Ebina Y, Fujimoto S. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet. 2001;103:241-244. Available: http://www.ncbi.nlm.nih.gov/pubmed/11745998 PMID: 11745998
22. Häkli T, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Endothelial nitric oxide synthase polymorphism in preeclampsia. J Soc Gynecol Investig. 2003;10:154-157. Available: http://www.ncbi.nlm.nih.gov/pubmed/12699878 PMID: 12699878
23. Landau R, Xie HG, Dishy V, Wood AJ, Stein CM, Smiley RM. No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia. Am J Hypertens. 2004;17:391-394. doi: 10.1016/j.amjhyper.2004.01.006 PMID: 15110896
24. Serrano NC, Casas JP, Díaz LA, Páez C, Mesa CM, Cifuentes R, et al. Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. Hypertension. 2004;44:702-707. doi: 10.1161/01. HYP.0000143483.66701.ec PMID: 15364897
25. Yu CK, Casas JP, Savvidou MD, Sahemey MK, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis. BMC Pregnancy Childbirth. 2006;6:7. doi: 10.1186/1471-2393-6-7 PMID: 16542455
26. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M, et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T->C mutation associated with coronary spastic angina. Hum Mol Genet. 2000;9:2629-2637. Available: http://www.ncbi.nlm.nih.gov/pubmed/11063722 PMID: 11063722
27. Fernandez-Patron C, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res. 1999;85:906-911. Available: http://www.ncbi. nlm.nih.gov/pubmed/10559137 PMID: 10559137
28. Fernandez-Patron C, Stewart KG, Zhang Y, Koivunen E, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res. 2000;87:670-676. Available: http://www.ncbi.nlm.nih.gov/pubmed/11029402 PMID: 11029402
29. Myers JE, Merchant SJ, Macleod M, Mires GJ, Baker PN, Davidge ST. MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia. Hypertens Pregnancy. 2005;24:103-115. doi: 10.1081/PRG-200059836 PMID: 16036395
30. Palei AC, Sandrim VC, Amaral LM, Machado JS, Cavalli RC, Duarte G, et al. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy. Exp Mol Pathol. 2012;92:217-221. doi: 10.1016/j.yexmp. 2012.01.008 PMID: 22327101
31. Zhang J, Gruber BL, Marchese MJ, Zucker S, Schwartz LB, Kew RR. Mast cell tryptase does not alter matrix metalloproteinase expression in human dermal fibroblasts: further evidence that proteolyticallyactive tryptase is a potent fibrogenic factor. J Cell Physiol. 1999;181:312-318. doi: 10.1002/(SICI) 1097-4652 (199911) 181:2<312::AID-JCP13>3.0. CO;2-1 PMID: 10497310
32. Pöllänen PJ, Karhunen PJ, Mikkelsson J, Laippala P, Perola M, Penttilä A, et al. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arter Thromb Vasc Biol. 2001;21:1446-1450. Available: http://www.ncbi.nlm.nih.gov/pubmed/11557670
33. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003;107:1579-1585. doi: 10.1161/01. CIR.0000058700.41738.12 PMID: 12668489
34. Morgan AR, Zhang B, Tapper W, Collins A, Ye S. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med. 2003;81:321-326. doi: 10.1007/s00109-003-0441-z PMID: 12728308
35. Fraser R, Walker JJ, Ekbote U V, Martin KL, McShane P, Orsi NM. Interleukin-4-590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9-1562 (C>T) polymorphisms in pre-eclampsia. BJOG. 2008;115:1052-6; discussion 1056. doi: 10.1111/j.1471-0528.2008.01771.x PMID: 18651887
36. Luizon MR, Palei AC, Sandrim VC. Polymorphisms and haplotypes in candidate genes related to angiogenesis and endothelial dysfunction in preeclampsia. J Pregnancy. 2012;2012:914704. doi: 10.1155/2012/914704 PMID: 22570788
37. Palei AC, Sandrim VC, Amaral LM, Machado JS, Cavalli RC, Lacchini R, et al. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. Pharmacogenomics J. 2012;12:489-498. doi: 10.1038/tpj.2011. 31 PMID: 21769110
38. Rahimi Z, Aghaei A, Vaisi-Raygani A. AT2R-1332 G:A polymorphism and its interaction with AT1R 1166 A:C, ACE I/D and MMP-9-1562 C:T polymorphisms: risk factors for susceptibility to preeclampsia. Gene. 2014;538:176-181. doi: 10.1016/j.gene.2013.12.013 PMID: 24440243
39. Bulletins-Obstetrics AC on P. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obs Gynecol. 2002;99:159-167. Available: http://www.ncbi.nlm.nih.gov/pubmed/16175681
40. Davis LG, Dibner MD, Battey JF. Basic Method in Molecular Biology. London: Elsevier; 1986.
41. Dai B, Liu T, Zhang B, Zhang X, Wang Z. The polymorphism for endothelial nitric oxide synthase gene, the level of nitric oxide and the risk for pre-eclampsia: a meta-analysis. Gene. 2013;519:187-193. doi: 10.1016/j.gene.2013.01.004 PMID: 23375994
42. Palei AC, Sandrim VC, Amaral LM, Machado JS, Cavalli RC, Lacchini R, et al. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy. Basic Clin Pharmacol Toxicol. 2012;111:262-267. doi: 10.1111/j.1742-7843.2012.00905.x PMID: 22672240
43. Bonifaz-Peña V, Contreras A V, Struchiner CJ, Roela RA, Furuya-Mazzotti TK, Chammas R, et al. Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations. PLoS One. 2014;9:e112640. doi: 10.1371/journal.pone.0112640 PMID: 25419701
44. Rodrigues de Moura R, Coelho A V, de Queiroz Balbino V, Crovella S, Brandão LA. Meta-analysis of Brazilian genetic admixture and comparison with other Latin America countries. Am J Hum Biol. 2015; doi: 10.1002/ajhb.22714
45. Alpoim PN, Gomes KB, Pinheiro M. B, Godoi LC, Jardim LL, Muniz LG, et al. Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia. Nitric Oxide. 2014;42:19-23. doi: 10.1016/j.niox.2014.07.006 PMID: 25106888
46. Sandrim VC, Palei AC, Cavalli RC, Araújo FM, Ramos ES, Duarte G, et al. eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics. 2008;9:1467-1473. doi: 10. 2217/14622416.9.10.1467 PMID: 18855535
47. Sandrim VC, Palei AC, Sertorio JT, Cavalli RC, Duarte G, Tanus-Santos JE. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Mol Hum Reprod. 2010;16:506-510. doi: 10.1093/molehr/gaq030 PMID: 20457799
48. Wang XL, Sim AS, Wang MX, Murrell GA, Trudinger B, Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000;471:45-50. Available: http://www.ncbi.nlm.nih.gov/pubmed/10760510 PMID: 10760510
49. Seremak-Mrozikiewicz A, Drews K, Barlik M, Sieroszewski P, Grzes̈kowiak E, Mrozikiewicz P. The significance of -786T > C polymorphism of endothelial NO synthase (eNOS) gene in severe preeclampsia. J Matern Fetal Neonatal Med. 2011;24:432-436. doi: 10.3109/14767058.2010.511329 PMID: 20822330
50. MacArthur DG, Manolio TA, Dimmock DP, Rehm HL, Shendure J, Abecasis GR, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508:469-476. doi: 10. 1038/nature13127 PMID: 24759409